ARTICLE | Company News
GenMark Diagnostics, Miraca deal
November 8, 2010 8:00 AM UTC
GenMark received non-exclusive, U.S. rights to Innogenetics N.V.'s HCV genotyping IP and an option to obtain worldwide rights to the technology. GenMark will use the technology to expand its diagnosti...